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Background: Children and adolescents with end-stage renal disease (ESRD) in sub-Saharan Africa may have the
worst outcomes globally. Barriers to management include late presentation, poor socioeconomic conditions,
absence of medical insurance, limited diagnostic facilities and non-availability of chronic renal replacement therapy
(RRT). Our study was to determine the incidence, aetiology, management and outcomes of paediatric ESRD in a
tertiary hospital in Nigeria.
Methods: A retrospective case review of paediatric ESRD at the University College Hospital Ibadan, Nigeria, over
8 years, from January 2005 to December 2012.
Results: 53 patients (56.6% male), median age 11 (inter quartile range 8.5-12) years were studied. Mean annual
incidence of ESRD in Ibadan for children aged 14 years and below was 4 per million age related population
(PMARP) while for those aged 5-14 years it was 6.0 PMARP. Glomerulonephritis was the cause in 41 (77.4%) patients
amongst whom, 29 had chronic glomerulonephritis and 12 had nephrotic syndrome. Congenital anomalies of the
kidneys and urinary tract (CAKUT) accounted for 11 (21.2%) cases, posterior urethral valves being the most common.
Acute haemodialysis, acute peritoneal dialysis or a combination of these were performed in 33 (62.3%), 6 (11.3%)
and 4 (7.5%) patients respectively. Median survival was 47 days and in-hospital mortality was 59%.
Conclusions: Incidence of paediatric ESRD in Ibadan is higher than previous reports from sub-Saharan Africa.
Glomerulonephritis, and then CAKUT are the most common causes. Mortality is high, primarily due to lack of
resources. Preventive nephrology and chronic RRT programmes are urgently needed.
Keywords: End-stage renal disease, Children, Chronic kidney disease, Glomerulonephritis, Congenital anomalies of
the kidneys and urinary tract, Nephrotic syndrome, NigeriaBackground
End-stage renal disease (ESRD) is an important cause of
morbidity and mortality among children in sub-Saharan
Africa. Managing ESRD in this region is particularly
challenging due to late presentation of patients, poor
socioeconomic conditions, absence of medical insurance,
inadequate health care infrastructure, and poor govern-
ment support. Chronic renal replacement therapy (RRT)
is generally unavailable to children. Due to a combination
of the afore-mentioned factors, children with ESRD in
sub-Saharan Africa may have the poorest outcomes* Correspondence: dr_deboademola@yahoo.co.uk
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unless otherwise stated.globally, even when compared with emerging economies
outside Africa [1-4].
Conversely, prognosis of paediatric ESRD has improved
in developed countries because most, if not all affected
children can access chronic peritoneal dialysis (PD),
haemodialysis (HD) or kidney transplantation [5-7]. Fur-
thermore, there are large renal registries in North
America, Europe and Australia which monitor trends in
incidence, prevalence and outcomes in children with
ESRD [8-11]. These registries provide valuable data for
planning and delivering health services to improve the
quality of life and outcomes of children with ESRD.
By contrast, paucity of such data exists in sub-Saharan
Africa [1,2,12,13], without which, advocacy, development
of intervention strategies, and evaluation of effectiveness
of interventions are restricted. This study aims to make aLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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management and outcomes of paediatric ESRD in a ter-
tiary hospital in Nigeria.
Methods
The University College Hospital Ibadan is a large tertiary
care referral centre located in Ibadan, the capital city of
Oyo State, in South West, Nigeria. Patients come from
Ibadan, other parts of Oyo State and beyond. Approxi-
mately 68% of the population of Nigeria live below the
United Nations Children’s Fund (UNICEF) poverty line
of 1.25 dollars per day [14]. Patients are required to pay
out-of-pocket for medical care, including RRT. The Na-
tional Health Insurance is limited to a minority of em-
ployees of the Federal Government as of now and does
not include the cost of dialysis or kidney transplantation.
According to the 2006 national census, Oyo State has
a population of 5,580,894 and a growth rate of 3.35%.
The population of children aged ≤ 14 years in Oyo state
is 2,099,694, while that of children aged 5-14 years is
1,385,660. While Ibadan, the capital city, has a popula-
tion of 2,560,573 with populations of children aged ≤ 14
years and those aged between 5-14 years in Ibadan
949,639 and 608,012 respectively [15-17].
The hospital’s paediatric nephrology unit is the only
one in Oyo state. It offers acute peritoneal dialysis with
rigid or adapted catheters and acute haemodialysis [18].
Chronic dialysis is not available due to barriers related
to cost. Kidney transplantation have recently become
available in the adult nephrology unit (four have been
performed) and there are ongoing efforts to extend these
services to children.
As a retrospective study, case records of all the pa-
tients who were managed for ESRD in the Paediatric
Nephrology Unit of the hospital from January 2005 to
December 2012 (96 months) were reviewed. Demo-
graphic, clinical, anthropometric, laboratory, aetiology of
ESRD, and RRT modality data were extracted and en-
tered into a questionnaire and subsequently into the
Statistical Package for Social Sciences (SPSS) version 17
(Reproduced 2008, SPSS Statistics for Windows, Version
17. Chicago: SPSS Inc.) spread sheet.
ESRD was defined as need for dialysis, commencement
of dialysis or death from renal failure in patients with
chronic kidney disease (CKD) [19]. Chronic kidney dis-
ease was defined as kidney damage or glomerular filtra-
tion rate of <60 ml/min/1.73 m2 for ≥ 3 months, and
kidney damage was defined as pathologic abnormalities
or markers of damage on urine, blood or imaging tests
[19]. For patients who presented to us in ESRD and were
followed up for less than 3 months, the diagnosis of
background CKD was made from the patient’s clinical
history or if the patient was stunted (height < 3rd per-
centile) [20]. Chronic Kidney disease was also diagnosedif the patient had congenital anomalies of the kidneys
and urinary tract (CAKUT) or ultrasound finding of
shrunken kidneys [19,21]. Nephrotic syndrome was de-
fined as massive proteinuria (dipstick urinalysis ≥ 3+
proteinuria or 24 hour urinary protein of 40 mg/m2/
hour) with serum albumin of <2.5 g/dl, oedema and
hyperlipidaemia [22]. Chronic glomerulonephritis (CGN)
was characterized by hypertension, renal failure, protein-
uria and haematuria. The term glomerulonephritis re-
ferred to nephrotic syndrome or CGN [22] CAKUT
were diagnosed on the basis of ultrasound, micturating
cysthourethrogram, or autopsy findings.
A primary outcome measure of in-hospital mortality
was determined as a recording of mortality was only
available for patients who died while admitted. The sec-
ondary outcome measure was the duration of survival in
ESRD. Mean or median and inter quartile range (IQR)
was calculated for continuous variables. Proportions
were determined for categorical variables. The numer-
ator for annual incidence of ESRD was children who
reached ESRD in the respective year, who were domi-
ciled in Ibadan and were managed in our hospital. The
denominator for the incidence of ESRD incidence was
the age related population of children in Ibadan for the
year based on the 2006 national census [15-17]. Inci-
dence of ESRD was not calculated for children aged 15
years and above because patients in this age group vari-
ably present to and are managed in the adult nephrology
unit. Data of patients managed in the adult unit were
not included in this study.
Kaplan Meier survival analysis was used to determine the
median survival time from the day of presentation in ESRD
to in-hospital mortality. Patients who were not hospitalized
or who were discharged home were censored. Cox propor-
tional hazard regression analysis model was used to assess
the effect of gender, age, presentation in ESRD, aetiology of
ESRD and acute dialysis, on duration of survival in ESRD.
For this analysis, age was grouped as 9 years and below ver-
sus 10 years and above; and aetiology of ESRD was grouped
as CAKUT and acquired (glomerulonephritis and malig-
nancy) causes. Patients were also grouped into those who
received any form of dialysis and those who did not. Statis-
tical analysis was done with the SPSS version 17 software.
Ethical approval for the study was obtained from the
University of Ibadan/University College Hospital (UI/UCH)
Ethics Committee and the study was performed in line with
the Declaration of Helsinki.
Results
Demographics
A total of 53 patients in ESRD, aged between 18 days and
17 years, were seen over a period of 96 months. There
were 30 males (56.6%). The median age at presentation in
ESRD was 11 (IQR 8.5-12) years. Four patients (7.5%)
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Fourteen patients (26.4%) were aged 5-9 years, while 28
(52.8%) were aged 10-14 years (See Table 1).
Thirty six patients (67.9%) lived in Ibadan, one (1.9%)
was from a town outside Ibadan but within Oyo state,
while the other 16 (30.2%) were from other states in
the country. Among the patients from Ibadan 32 (91.4%)
were aged 14 years and below, while 31 (86.1%) were aged
5-14 years. The mean annual incidence of ESRD among
children aged 14 years and below who were domiciled
in Ibadan was 4.0 per million age related population
(PMARP) while the mean incidence for children aged
5-14 years in Ibadan was 6.0 PMARP. The mean incidence
of ESRD for the years 2005 to 2008 and 2009-2012 among
children aged ≤ 14 years were 3.6 and 4.4 PMARP respect-
ively, while ESRD incidence for children aged 5 - 14 years
were 5.4 and 6.5 PMARP (See Figure 1).
Nineteen patients (35.8%) presented before the onset
of ESRD and subsequently progressed to ESRD; while 34
(64.2%) were already in established ESRD at the time of
initial presentation.
Aetiology of ESRD
Regarding children who presented before the onset of
ESRD, 11 (57.9%) presented with nephrotic syndrome,
while 5 (26.3%) presented with CGN. One of the patients
with nephrotic syndrome also had a solitary kidney. Cyan-
otic congenital heart disease, sickle cell anaemia and HIV
infection were the initial presentation in three patients.
Overall, ESRD was due to glomerulonephritis in 41




Gender Diagnosis ESRD at initial
presentation (N)GN CAKUT Malig H
0-4 F - 1 - 1
M - 3 - 3
Subtotal - 4 - 4
5-9 F 6 1 - 4
M 5 2 - 5
Subtotal 11 3 - 9
10-14 F 13 - - 8
M 12 3 - 9
Subtotal 25 3 - 17
15-19 F - 1 1 1
M 5 0 - 3
Subtotal 5 1 1 4
Total N (%) 41 (77.4) 11 (20.8) 1 (1.8) 34 (64.2) 3
CAKUT: Congenital Anomalies of the Kidneys and Urinary Tract; ESRD: End-stage ren
Malig: Malignancy; PD: Peritoneal dialysis.occurring in 29 (54.7%) and 12 (22.6%) of children re-
spectively. Seropositivity for HBsAg and HIV infection
was associated with glomerulonephritis in four and three
children respectively (See Table 2).
Renal biopsy was performed in seven children and
showed focal segmental glomerulosclerosis (FSGS) in
four patients. Diffuse global sclerosis, membranous ne-
phropathy and non-Hodgkin lymphoma of the kidneys
were observed in one patient each.
CAKUT was associated with ESRD in 11 patients
(20.8%). Five of these had posterior urethral valves
(PUV), while 2 had solitary kidney (See Table 2). Ten of
the 11 patients with CAKUT were already in established
ESRD at initial presentation to our facility. Apart from
sickle cell nephropathy, hereditary nephropathy was not
recorded in any child.
Management
Immunosuppressive treatment
Among the 11 children with nephrotic syndrome who
presented before the onset of ESRD, 6 had received
treatment with corticosteroids and were all steroid re-
sistant. Three children defaulted from follow up before
commencement of steroid therapy and later represented
in ESRD. The patient with nephrotic syndrome, cyanotic
congenital heart disease and polycythaemia was not of-
fered corticosteroids. The one with nephrotic syndrome
and solitary kidney had associated hypertension requir-
ing the use of combination anti hypertensive therapy
and also did not receive corticosteroid or other im-




D alone PD alone HD and PD None
- 1 - - 1 1
- 3 - - 3 3
- 4 - - 4 4 (7.5)
3 2 - 2 3 7
7 - - - 1 7
10 2 - 2 4 14 (26.4)
9 - 2 2 9 13
9 - 1 5 10 15
18 - 3 7 19 28 (52.8)
2 - - - 1 2
3 - 1 1 1 5
5 - 1 1 2 7 (13.2)
3 (62.3) 6 (11.3) 4 (7.5) 10 (18.9) 29 (54.7) 53 (100)
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Figure 1 Incidence, per million age related population, of end-stage renal disease (ESRD) for children and adolescents, by age group
and time period: University College Hospital Ibadan, Nigeria.
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Fifty one children were admitted into the hospital for
the management of ESRD, while 2 were managed on
outpatient basis only. Forty three children (81.8%)
altogether underwent acute dialysis. Thirty three patients
(62.3%) had intermittent HD alone, 6 (11.3%) had acute
PD alone, while 4 children (7.5%) underwent both inter-
mittent HD and acute PD (See Table 1). Two patients re-
ceived one session each of HD on out-patient basis
following discharge from the hospital, otherwise dialysis
took place while patients were on admission. One of the
patients with PUV proceeded to have valve ablation and
kidney transplantation in India. Chronic renal replace-
ment therapy could not be carried out in the other pa-
tients because of financial constraints.
Outcome
For the 19 patients who had presented before developing
ESRD, the time from initial presentation to presentation
in ESRD was a median of 28 (IQR 5 – 38) months. Fifty
one patients were hospitalised for ESRD management,
out of which 29 (59%) died in the hospital. The time
from presentation in ESRD to in-hospital mortality
ranged from 8 hours to 7.5 months, and median survival
was 47 (SE 15) days (See Figure 2). The Cox Propor-
tional Hazard regression analysis (Figure 3) showed that
patients who did not receive dialysis survived for signifi-
cantly less number of days than patients who did (p =
0.042, Hazard ratio: 2.9, 95% Confidence interval 1.039-
8.083). Age, gender, aetiology, and presentation in ESRDdid not have significant effect on survival when patients
were in ESRD.
Discussion
Children in ESRD are the most severely ill in the
spectrum of childhood chronic kidney disease (CKD),
and carry the highest risk for mortality. There are few
studies on childhood ESRD from sub-Saharan Africa
[1,2,12,13]. To the best of our knowledge none of the
studies were reported exclusively on children in ESRD
and therefore, our study adds important new informa-
tion to the epidemiology of ESRD among Nigerian chil-
dren. Our study showed that the incidence of paediatric
ESRD was higher than previously reported from our sub
region [1,2,13] but lower than those reported in devel-
oped countries [8,9,11,23]. Glomerulonephritis was the
commonest cause, followed by CAKUT. Management of
the patients was hampered by lack of funds and facilities
for chronic RRT resulting in high mortality.
This study noted a variation in the distribution of
ESRD within Oyo state with virtually all patients domi-
ciled in the state, coming from within Ibadan, the capital
city, where our hospital is located. This variation is most
likely due to differences in referral patterns of ESRD
within the state. Awareness, recognition and referral of
children with ESRD may be higher from communities
that are closer to the University College Hospital which
is the sole centre offering paediatric dialysis services in
Oyo State. Variation in reporting of ESRD by accessibil-
ity to health services has been previously documented
Table 2 Pattern of aetiology of end-stage renal disease







Unknown aetiology, n = 23
HIV seropositivity, n = 3
HBsAg seropositivity, n = 2
Sickle Cell Nephropathy, n = 1
Nephrotic syndrome 12
(22.6)
Unknown aetiology, n = 7
FSGS, n = 2
HBsAg seropositivity, n = 2




of the kidney and
urinary tract
PUV 6 (11.3)









aOne of the patients with right sided solitary kidneys presented with
nephrotic syndrome.
CCHDX: Cyanotic congenital heart disease; FSGS: Focal segmental
glomerulosclerosis; HBsAg: Hepatitis B surface antigen; HIV: Human
immunodeficiency virus; HIVAN: Human immunodeficiency virus-1-associated
nephropathy; PUV: Posterior urethral valves.
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in Jamaica and Chile [4,24]. Concentration of main
health resources and technology for the diagnosis and
treatment of renal diseases in metropolitan areas and
under reporting of kidney disease from other areas
are assumed to be reasons for differential referral pat-
terns [4,24].
The few studies on childhood ESRD from sub-Saharan
Africa, mainly from Nigeria [1,2] and South Africa [13],
also included patients with other stages of CKD and
found a CKD incidence of 1-3 per million children. The
present study found an ESRD incidence of 4 per million
children in Ibadan which was higher than findings from
other parts of Nigeria [1,2] or South Africa [13]. The
higher incidence of ESRD in our study compared to the
other Nigerian studies may be due to differences in re-
ferral patterns, while the higher incidence compared to
findings in South Africa may be related to variations in
genetic or environmental factors.Additionally we found an increasing incidence of
paediatric ESRD over the 4 year bands 2005-2008, and
2009-2012. This is similar to a report from the United
Kingdom which also noted a rising incidence in paediat-
ric RRT for ESRD over 3 consecutive 5 year bands from
1996-2010 [25]. The rising incidence of RRT in the
United Kingdom was attributed to increased provision
of dialysis to younger children due to improvements in
techniques for nutritional and dialysis support and in-
creasing referral of children who are younger than 16
years of age to paediatric units [25]. The rising incidence
of ESRD in the present study may be due to increasing
recognition and referral of children in ESRD.
The incidence of childhood ESRD observed in this
study is lower than that reported from many developed
countries. In the United States and Canada an ESRD in-
cidence of 9-16 per million is recorded for children aged
0-19 years [11]. The North American registries included
patients in the 15-19 year age group an age group re-
portedly having the highest incidence of paediatric ESRD
[9,11,23]. The incidence in Ibadan was also less than the
mean of 5.3 per million for children less than 14 years
old reported in European countries [8], or 10.9 per mil-
lion children as noted in Turkey [26]. It was however
much less than the 17 per million children noted in
Kuwait in the Middle East, where hereditary renal
diseases are common due to high prevalence of consan-
guinity [27]. Poor health seeking behaviour, under-
reporting of cases and referral patterns in poor resource
settings may also contribute to the low incidence in
Ibadan compared to developed nations. Additionally, the
lack of resources for appropriate consultations, medica-
tions, chronic dialysis and kidney transplantation for
children accelerates mortality in patients with both acute
and chronic kidney diseases leading to a lower incidence
and prevalence of ESRD in Ibadan and indeed in many
parts of sub-Saharan Africa.
The male predominance noted in this study is similar to
the observation in many other reports [11,23,25-29] in-
cluding studies done in Africa [1,2,12,13]. The male pre-
dominance, as in the other studies, is due to the higher
proportion of males among patients with CAKUT. Fur-
thermore, there are relatively few patients in the 0-5 year
age group in our study compared to other age groups in
our study. ESRD in younger children is mostly due to
CAKUT, while the contribution of glomerulonephritis to
ESRD increases with age [1,9,25,30,31]. The low number
of patients who are less than 5 years of age in our study
may reflect the finding of low numbers of patients with
CAKUT versus those with glomerulonephritis.
Glomerulonephritis was the leading cause of ESRD in
our study, accounting for approximately 80% of cases.
This was followed by CAKUT in approximately 20% of
our patients. This is in contrast to reports from Europe
Figure 2 Kaplan Meir survival curve of time from presentation in end-stage renal disease to in-hospital mortality, among 53 children
and adolescents: University College Hospital Ibadan, Nigeria, 2005-2012.
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and among whites in the United States [11] where
CAKUT are the largest causes of ESRD and are respon-
sible for 34% - 52% of cases of ESRD among children.
Glomerulonephritis accounts for 14 - 30% childhood
ESRD in these settings [8,9,11,23,27]. Among African
American children primary and secondary glomerulo-
nephritis were the leading cause of ESRD [11]. Reports
from India, South East Asia and South America indicateFigure 3 Plot of survival of 53 children and adolescents from present
management: University College Hospital Ibadan, Nigeria, 2005-2012that glomerulonephritis is the predominant cause of child-
hood CKD in developing countries [3,32-34]. Similarly in
a South African study [13] with 75% black participants
and in other studies from sub-Saharan Africa [1,2,12],
glomerulonephritis was the largest cause of CKD occur-
ring in 25.4 - 56.4% of children, while CAKUT occurred
in 17.5-37.3% of children [1,2,10,11]. The predominance
of glomerulonephritis followed by CAKUT among our pa-
tients is consistent with the observation in Africanation in ESRD to in-hospital mortality, by acute dialysis
.
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sub-Saharan Africa [1,2,11-13].
The large proportion of patients with glomeruloneph-
ritis compared to CAKUT in this study may be due to
both genetic and environmental factors. The renal biop-
sies, although few were performed, predominantly showed
FSGS. Among African American children, FSGS is three
times more common than in Caucasian children, suggest-
ing a genetic basis [10,28]. In Ibadan, where our hospital
is located, a strong association was previously found be-
tween APOL 1 variants and their two allele gene haplo-
types in a study of 166 adult Nigerian patients with non
diabetic kidney disease [35]. Furthermore, vesico-ureteral
reflux, a congenital anomaly which is commonly associ-
ated with renal hypoplasia and dysplasia and reflux ne-
phropathy among children in Europe, Asia, and the
Middle East and also among white Americans is less com-
mon among African Americans and in sub-Saharan Africa
[1,2,12,36-39].
The high prevalence of glomerulonephritis among
children in developing countries and in sub-Saharan
Africa has also been attributed to the high prevalence of
bacterial, protozoal or viral infections [40,41]. In our
study 20% of the patients with glomerulonephritis were
either seropositive for HIV or Hepatitis B surface anti-
gen. With increasing survival of HIV infected children
and reduction in mortality from infectious diseases, HIV
appears to be emerging as a cause of paediatric ESRD
[42-44]. It is not clear, however, if Hepatitis B virus in-
fection was the aetiology of ESRD in our patients or if it
was incidental [45].
The high proportion of patients with glomerulonephritis
among our patients compared with CAKUT might also
be due to patient selection. Our study evaluated only
children in ESRD. It is recognised that glomeruloneph-
ritis progresses to ESRD faster than CAKUT [36,46].
Additionally severe cases of CAKUT may have been
missed as they might have died in infancy or early child-
hood without diagnosis.
The majority (60%) of our patients already had ESRD
at the time of their initial presentation. This pattern of
late presentation has been noted in developing countries
like India [31,32], Jamaica [4] and Syria [47], where
ESRD was present in 20-55.5% of children with CKD at
presentation. Late presentation has also been noted
among ethnic minorities in the UK [48]. In contrast,
among children in the North American Renal Trans-
plant and Cooperative Study (NAPRTCS), with many of
the contributing centres in developed countries, only
4.3% were in ESRD at entry into the study [10]. The
early features of CKD may not be overt and may have
been missed by the caregivers leading to late presenta-
tion in some of our patients. Furthermore there may be
low priority for screening and referral of children forkidney disease in many primary and secondary health fa-
cilities in Nigeria because chronic renal replacement is
expensive and not readily available. Early diagnosis of
kidney disease may, however, allow institution of therapy
that will potentially prevent or slow the progression to
ESRD [22]. Efforts to increase awareness of childhood
kidney disease among the public and health workers, to
promote early diagnosis, referral and treatment of kidney
disease among children are needed.
Access to chronic RRT has improved the outcome of
ESRD in developed countries. The case fatality ratio de-
creased from 11.0 per 100 patient years in the 1960s to
1.3 per 100 patient years in 2002-2004 [7,49]. Long term
survival rate for children on chronic RRT in developed
countries is 79% at 10 years and 66% at 20 years [6,28].
Transplant patients consistently have a 4 fold survival
advantage compared with dialysis patients [6,11]. Life
expectancy among young adults who started RRT in
childhood is 38 years for patients remaining on dialysis
compared to 68 years for those with a functioning graft
[50]. In developed countries, deaths in children from
ESRD now occur mainly from infections and cardiovas-
cular disease rather than renal failure in contrast to the
pattern in developing countries [28]. Although we of-
fered acute dialysis to more patients in ESRD than in
previous Nigerian reports on paediatric ESRD, in the ab-
sence of chronic RRT outcome remained very poor. Pa-
tients who were discharged home would have died at
home shortly after discharge in the absence of chronic
RRT. Similar high mortality was noted in previous re-
ports from Nigeria [1,2]. Some centres in the country,
including ours, have started performing kidney trans-
plantation, the financial implication (including cost of
immunosuppressive medications) is, however, prohibitive
for most Nigerians. The absence of chronic renal re-
placement therapy was the cause of the high mortality in
our patients.
Our study has a number of limitations, one of which is
that it reflects a single centre hospital based incidence and
the data is likely an underestimate of the true incidence of
ESRD since many patients may not present or continue
follow up at a tertiary care centre. A prospective multicen-
tre study may give a better estimate, although prospective
community based study will be ideal. Another limitation
of our study is that the aetiology of chronic glomerulo-
nephritis was not determined in many of our patients and
that few renal biopsies were performed. In sub-Saharan
Africa late presentation and limited diagnostic facilities,
including facilities for immunofluorescence and electron
microscopy of renal biopsies, make it difficult to deter-
mine the aetiology of glomerulonephritis in many patients.
Multicentre and prospective studies are needed to accur-
ately determine the aetiology of chronic glomeruloneph-
ritis in sub-Saharan Africa. The study however indicates
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may be higher than previously reported and underscores
the high mortality associated with this condition in sub-
Saharan Africa.
In view of the high mortality associated with ESRD in
settings with very limited access to chronic RRT, urgent
steps need to be taken in the areas of preventive neph-
rology, development of a public-funded chronic RRT
program, and setting up of a national registry for paedi-
atric ESRD. Programs that increase awareness of kidney
disease among the public and health workers may lead
to earlier presentation, detection and management of
kidney disease. Optimal management of patients with
glomerulonephritis is needed with adequate laboratory
back up and access to medications. Early diagnosis and
appropriate management of children with CAKUT may
reduce mortality; it is however unclear if management
will improve long term renal outcomes especially with
posterior urethral valves [51,52]. A public-funded chronic
RRT program is therefore needed to improve access to
dialysis and kidney transplantation and potentially lead to
improved prognosis. Nigerian nephrologists and other
stake holders should continue to provide advocacy for the
National Health Insurance to be expanded to include a
larger proportion of the population and the cost of
chronic RRT. The setting up of a national registry of
paediatric ESRD will provide important data for advocacy,
to monitor outcome of interventions and national trends
in paediatric ESRD. In addition to governmental support,
that from non-governmental bodies and individuals is re-
quired to achieve sustained improvement of paediatric
nephrology services and research in Nigeria and sub-
Saharan Africa.
Conclusion
In conclusion, the incidence of ESRD in our study is
higher than in previous Nigerian studies. Glomerulo-
nephritis is the commonest cause followed by CAKUT.
Prognosis remains poor in the absence of chronic RRT.
Preventive nephrology and public-funded chronic RRT
programmes are urgently needed.
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